All posts by: Michael Zand

About Michael Zand

Cynata Therapeutics advance to second cohort in stem cell trial – Small Caps

Continue reading

2018-01-22 NEWS

Small Caps

Cynata Therapeutics advance to second cohort in stem cell trial
Small Caps
Stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has received an encouraging early response from the clinical trials of its stem cell product CYP-001, which began in November to treat steroid-resistant graft-versus-host
Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to …Nasdaq
HC Wainright repeats ‘buy’ on Cynata as ongoing trial is cleared by data safety monitoring boardProactive Investors UK

all 4 news articles »

Continue reading

2018-01-22 NEWS

Stem Cells for Urinary Incontinence: Functional Differentiation or Cytokine Effects?
UroToday
Clinical trials of periurethral stem cell injection have been underway and basic science research has demonstrated the efficacy of both local and systemic stem cell therapies. Results differ as to whether stem cells have a therapeutic effect by
Erectile Dysfunction And Stem Cell TherapyCheckbiotech.org (press release)
Perinatal Stem Cells. 2nd Edition – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health IndustriesMilTech
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury …satPRnews (press release)

all 9 news articles »

Continue reading

2018-01-21 NEWS

ArchDaily

Living Architecture ‘Astrocyte’ Questions Whether Buildings Can Think and Care
ArchDaily
The synthetic biology system has the potential to self-repair and alters space through the kinetic mechanisms that integrate structure and motion – two opposing characteristics. Together they connect with humans much like how nature does in the

and more »